Augmedix, a US-based developer of automation healthcare technology, has raised $19m in its series B round that includes investments from a consortium including McKesson Ventures, the eponymous pharmaceutical firm’s corporate venturing unit.
The other investors included Redmile Group, DCM Ventures and Wanxiang Healthcare Investments.
Tom Rodgers, senior vice president and managing director at McKesson Ventures, said: “Augmedix is uniquely positioned to leverage trained medical documentation experts, increasingly enabled by artificial intelligence, to deliver a consumer-grade experience for the clinician that…
